Prevention and Arrest of Root Caries Lesions with High Fluoride Concentration Mouthwash Versus Normal Fluoride Concentration Mouthwash in Elderly Patients
NCT ID: NCT06723054
Last Updated: 2024-12-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
69 participants
INTERVENTIONAL
2023-02-01
2025-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Mouth rinses are considered as cosmetic products and are available as OTC products and do not require prescriptions. They are also relatively less expensive in comparison to the high fluoride toothpastes. Fluoridated mouthwashes are generally recommended in moderate-high caries risk population or individual. The normal fluoride range in a mouth wash is normally between 100 ppm to 500 ppm F. This may not be sufficient to bring a preventive effect in high risk individuals. It has been demonstrated that a small positive trend for sodium fluoride (NaF) mouth rinses against placebo in reducing the initiation of coronal and root caries.
Erythritol is a natural sugar substitute and is frequently used as a sweetener. It is easily excreted by the kidneys and does not increase the blood sugar. It is often an additive in mouthwashes as a sweetening agent. It is known to have anti-plaque aggregating and bacteriostatic effect.
Perhaps, the use of erythritol in regular fluoride mouthwash (220 ppm F) in combination with high F mouthwash (500 ppm F) might be beneficial and augment the preventive effect of fluoride in mouth rinses. This may be a viable alternative to expensive and prescription options.
Therefore, the primary objective of this study is to evaluate the effectiveness of regular fluoride 220 ppm F with erythritol and high fluoride 500 ppm F with erythritol mouthwashes against a placebo (regular fluoride 220 ppm F mouthwash) in the prevention of new root caries lesions.
The secondary endpoints/outcome set for this study is the number of arrested root surface caries after intervention with the test products (i.e., a change of root surface caries from ICDAS classification 1 to 2 and 3 to 4, respectively will be considered as arresting).
The tertiary endpoint/outcome set for this study are as follows: 1. Incidence of new coronal caries after the intervention with the test products and 2. the number of arrested coronal caries after the intervention with the test products.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group (CG)
Regular fluoride 220 ppm F mouthwash without erythritol
regular fluoride 220 ppm F mouthwash without erythritol
The participants will be asked to rinse once daily with a regular fluoride 220 ppm F mouthwash without erythritol.
Intervention group #1 (IG1)
220 ppm F mouthwash with erythritol
regular fluoride 220 ppm F mouthwash with erythritol
The participants will be asked to rinse once daily with a regular fluoride 220 ppm F mouthwash with erythritol.
Intervention group #2 (IG2)
500 ppm F mouthwash with erythritol
high fluoride 500 ppm F mouthwash with erythritol
The participants will be asked to rinse once daily with a high fluoride 500 ppm F mouthwash with erythritol.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
regular fluoride 220 ppm F mouthwash without erythritol
The participants will be asked to rinse once daily with a regular fluoride 220 ppm F mouthwash without erythritol.
regular fluoride 220 ppm F mouthwash with erythritol
The participants will be asked to rinse once daily with a regular fluoride 220 ppm F mouthwash with erythritol.
high fluoride 500 ppm F mouthwash with erythritol
The participants will be asked to rinse once daily with a high fluoride 500 ppm F mouthwash with erythritol.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Dentinal root caries lesions with no painful symptomology
* Minimum of 3 teeth present in the mouth
* Can follow instructions for oral hygiene
Exclusion Criteria
* Root surface active lesion which is easily penetrated by sharp probe with light force (ICDAS Grade 3 and soft needs to be filled)
* Non-carious attrition, erosion or abrasion cavities
* Periodontally compromised teeth with Grade 3 mobility, and active signs of infections.
* Not willing or able to sign informed consent
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Murali Srinivasan, Dr. med. dent., BDS, MDS, MBA, MAS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Murali Srinivasan, Dr. med. dent., BDS, MDS, MBA, MAS
Prof. Dr. med. dent.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Zurich, Center for Dental Medicine, Clinic of General, Special care, and Geriatric Dentistry
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UZH_ABS_2021_9
Identifier Type: OTHER
Identifier Source: secondary_id
UZH_ABS_2021_9
Identifier Type: -
Identifier Source: org_study_id